Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review
Toxins · 2023
DOI: 10.3390/toxins15060391 ↗Kurz gefasst
Scoping Review in der Zeitschrift Toxins, 2023. Verfasst von Roberto Erro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Via Allende 43, 84081 Baronis…. Hauptthemen laut MEDLINE: Torticollis, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical dstonia (CD) is a chronic disorder with a significant detrimental impact on quality of life, requiring long-term treatment. Intramuscular injections of botulinum neurotoxin (BoNT) every 12 to 16 weeks have become the first-line option for CD. Despite the remarkable efficacy of BoNT as a treatment for CD, a significantly high proportion of patients report poor outcomes and discontinue the treatment. The reasons that drive sub-optimal response or treatment failure in a proportion of patients include but are not limited to inappropriate muscle targets and/or BoNT dosing, improper method of injections, subjective feeling of inefficacy, and the formation of neutralizing antibodies against the neurotoxin. The current review aims to complement published research focusing on the identification of the factors that might explain the failure of BoNT treatment in CD, highlighting possible solutions to improve its outcomes. Thus, the use of the new phenomenological classification of cervical dystonia known as COL-CAP might improve the identification of the muscle targets, but more sensitive information might come from the use of kinematic or scintigraphic techniques and the use of electromyographic or ultrasound guidance might ensure the accuracy of the injections. Suggestions are made for the development of a patient-centered model for the management of cervical dystonia and to emphasize that unmet needs in the field are to increase awareness about the non-motor spectrum of CD, which might influence the perception of the efficacy from BoNT injections, and the development of dedicated rehabilitation programs for CD that might enhance its effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Via Allende 43, 84081 Baronissi, SA, Italy.
ORCID-Profile: Roberto Erro
Zitieren
APA
Erro, R., Picillo, M., Pellecchia, M. T., & Barone, P. (2023). Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins. https://doi.org/10.3390/toxins15060391
Vancouver
Erro R, Picillo M, Pellecchia MT, Barone P. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins. 2023. doi:10.3390/toxins15060391
BibTeX
@article{Erro2023,
author = {Erro, Roberto and Picillo, Marina and Pellecchia, Maria Teresa and Barone, Paolo},
title = {Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review},
journal = {Toxins},
year = {2023},
doi = {10.3390/toxins15060391}
}
EUVIMED